CEND/IVRI Symposium on Immunotherapy at UC Berkeley
March 7th, 2016
The CRL is joining forces with two campus organizations to sponsor an exciting new Symposium at UC Berkeley on Immunotherapy.
The CRL will join the Henry Wheeler Center for Emerging & Neglected Diseases (CEND) and the new Immunotherapeutics and Vaccine Research Initiative (IVRI) to sponsor a Symposium that aims to strengthen connections between scientists working on infectious diseases and cancer. The common focus is to discuss the potential of immunotherapy to address both diseases.
The speaker lineup includes leading figures in immunology and vaccinology at the forefront of developing immune based science to tackle the twin scourges of cancer and infectious diseases.
The Symposium will be held Friday, March 25, 2016 from 9:00 AM to 5:00 PM (PDT), Li Ka Shing Center Auditorium, Room 245.
Networking reception and poster session to follow at 5:00 pm to 6:00pm.
- Rafi Ahmed, Emory University
- James P. Allison, M.D. Anderson Cancer Center
- Nina Bhardwaj, Icahn School of Medicine at Mt. Sinai Hospital
- Tom Dubensky, Aduro Biotech
- Ira Mellman, Genentech
- Louis J. Picker, Oregon Health and Sciences University
The Symposium is free. Register at http://tinyurl.com/zlxy9tv
More information here: http://cend.globalhealth.berkeley.edu/symposia-seminar-series/cend-annual-symposium/